Position in ALKS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$126,861,238
+$21,885,001 QoQ
Shares Held
2,421,016
-18.5% QoQ
Ownership
1.44%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#16
of 421 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
This page
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,861,238 | 2,421,016 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $104,976,237 | 2,968,785 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $40,682,975 | 1,454,002 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $41,940,630 | 1,398,021 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $39,976,209 | 1,397,281 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $53,526,938 | 1,621,046 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $42,957,402 | 1,493,651 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $49,853,968 | 1,781,135 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $37,068,499 | 1,538,112 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $39,870,536 | 1,472,868 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $45,799,849 | 1,651,040 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $41,672,969 | 1,487,789 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $53,947,709 | 1,723,569 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $54,139,430 | 1,920,519 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $52,493,732 | 2,008,945 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $37,692,481 | 1,687,975 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $54,664,322 | 1,834,989 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $53,687,765 | 2,040,584 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $48,474,026 | 2,084,008 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $83,736,582 | 2,715,194 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $77,269,606 | 3,151,289 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $61,016,669 | 3,266,417 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $77,337,651 | 3,876,574 | Shares | Sole | 2021-02-02 | |
| 2020-06-30 | $77,567,755 | 3,996,278 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $42,617,257 | 2,955,427 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||